For over a decade, animal research has demonstrated the ability of both agonists and antagonists to modulate alcohol consumption. More recently, two human trials have suggested that naltrexone is effective in decreasing relapse in recently abstinent alcoholics during ongoing rehabilitation services. The primary objectives of the proposed clinical pharmacology laboratory trial are: to determine a dose-effect function of naltrexone on subjective, physiological, neuroendocrine and psychomotor measures of acute alcohol intoxication; to determine the time course of effects and examine specific effects on the ascending vs. descending BAL limbs; to examine effects of naltrexone on alcohol pharmacodynamics; and to provide information on potential mechanisms for naltrexone effects in decreasing alcohol consumption in recently abstinent alcohol-dependent patients. Subjects were community-recruited, heavy drinking subjects, with no current medical or psychiatric problems. All subjects were admitted to the GCRC for three, 8-day experimental periods separated by a one week washout period to allow for randomization of chronic naltrexone dosing without carryover effects. Each subject received each naltrexone maintenance dose (0, 50 and 100 mg) once in random order over the course of the three experimental periods. Beginning on the day of admission and for the duration of each experimental period, subjects were maintained on a single dose of naltrexone with once daily dosing. Once steady state naltrexone levels had been achieved by day 4, subjects participated in three alcohol challenge sessions (0.0, 0.6 and 1.0 mg/kg) in random order on days 4, 6 and 8 of the experimental period. Physiologic, subjective and psychomotor performance effects were assessesd during each experimental session. We have recently completed subject recruitment and participation in the experimental sessions, and are currently analyzing study data. Preliminary findings suggest few differences in subjective or physiological responses following alcohol challenges across the naltrexone doses. A competitive renewal application will be submitted in April, 1997.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
3M01RR002719-12S1
Application #
2756404
Study Section
Project Start
Project End
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
12
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Unick, Jessica L; Gaussoin, Sarah A; Hill, James O et al. (2017) Objectively Assessed Physical Activity and Weight Loss Maintenance among Individuals Enrolled in a Lifestyle Intervention. Obesity (Silver Spring) 25:1903-1909
Li, Tianjing; Wieland, L Susan; Oh, Esther et al. (2017) Design considerations of a randomized controlled trial of sedation level during hip fracture repair surgery: a strategy to reduce the incidence of postoperative delirium in elderly patients. Clin Trials 14:299-307
Sammut, Amanda; Shea, Steven; Blumenthal, Roger S et al. (2017) Albuminuria in Rheumatoid Arthritis: Associations With Rheumatoid Arthritis Characteristics and Subclinical Atherosclerosis. Arthritis Care Res (Hoboken) 69:1799-1808
Baker, Joshua F; Giles, Jon T; Weber, David et al. (2017) Assessment of muscle mass relative to fat mass and associations with physical functioning in rheumatoid arthritis. Rheumatology (Oxford) 56:981-988
Johnson, Karen C; Bray, George A; Cheskin, Lawrence J et al. (2017) The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial. J Bone Miner Res 32:2278-2287
Chao, Ariana M; Wadden, Thomas A; Gorin, Amy A et al. (2017) Binge Eating and Weight Loss Outcomes in Individuals with Type 2 Diabetes: 4-Year Results from the Look AHEAD Study. Obesity (Silver Spring) 25:1830-1837
Park, H-W; Tse, S; Yang, W et al. (2017) A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment. Pharmacogenomics J 17:180-185
McGeachie, Michael J; Yates, Katherine P; Zhou, Xiaobo et al. (2016) Genetics and Genomics of Longitudinal Lung Function Patterns in Individuals with Asthma. Am J Respir Crit Care Med 194:1465-1474
Marquez, Becky; Anderson, Andrea; Wing, Rena R et al. (2016) The relationship of social support with treatment adherence and weight loss in Latinos with type 2 diabetes. Obesity (Silver Spring) 24:568-75
Kavouspour, Chitra; Wang, NaeYuh; Mears, Simon C et al. (2016) Surgical procedure and postoperative delirium in geriatric hip fracture patients. Eur J Anaesthesiol 33:230-1

Showing the most recent 10 out of 406 publications